P

Inventor

MENG WEI

CN64 patents
⚠️ This page may combine multiple inventors who share the name “MENG WEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

24 patents
US6515117B2Feb 4, 2003

C-aryl glucoside SGLT2 inhibitors and method

BRISTOL MYERS SQUIBB CO372 citations98
US6414126B1Jul 2, 2002

C-aryl glucoside SGLT2 inhibitors and method

BRISTOL MYERS SQUIBB CO380 citations98
US6936590B2Aug 30, 2005

C-aryl glucoside SGLT2 inhibitors and method

BRISTOL MYERS SQUIBB CO133 citations97
US7589193B2Sep 15, 2009

C-aryl glucoside SGLT2 inhibitors and method

BRISTOL MYERS SQUIBB CO67 citations94
US8791091B2Jul 29, 2014

Aryl dihydropyridinone and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO18 citations92
US9701672B2Jul 11, 2017

Dihydropyridinone MGAT2 inhibitors for use in the treatment of metabolic disorders

BRISTOL MYERS SQUIBB CO8 citations84
US9901572B2Feb 27, 2018

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO6 citations83
US9663466B2May 30, 2017

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO8 citations83
US9187424B1Nov 17, 2015

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO10 citations83
US7365061B2Apr 29, 2008

2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors

BRISTOL MYERS SQUIBB CO12 citations83
US9856244B2Jan 2, 2018

Dihydropyridinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO2 citations73
US10695328B2Jun 30, 2020

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO2 citations72
US10369140B2Aug 6, 2019

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO3 citations72
US10106528B2Oct 23, 2018

6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists

BRISTOL MYERS SQUIBB CO3 citations71
US7223786B2May 29, 2007

2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors

BRISTOL MYERS SQUIBB CO2 citations63
US12168655B2Dec 17, 2024

Apelin receptor agonists and methods of use

BRISTOL MYERS SQUIBB CO0 citations62
US11390616B2Jul 19, 2022

Apelin receptor agonists and methods of use

BRISTOL MYERS SQUIBB CO1 citations62
US10966967B2Apr 6, 2021

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

BRISTOL MYERS SQUIBB CO0 citations62
US7910747B2Mar 22, 2011

Phosphonate and phosphinate pyrazolylamide glucokinase activators

BRISTOL MYERS SQUIBB CO3 citations62
US10889565B2Jan 12, 2021

4-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonists

BRISTOL MYERS SQUIBB CO0 citations51
US10604541B2Mar 31, 2020

Glucokinase activators and methods of using same

BRISTOL MYERS SQUIBB CO0 citations51
US10590113B2Mar 17, 2020

6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists

BRISTOL MYERS SQUIBB CO0 citations51
US7635699B2Dec 22, 2009

Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods

BRISTOL MYERS SQUIBB CO1 citations50
US7342127B2Mar 11, 2008

Substituted anilide ligands for the thyroid receptor

BRISTOL MYERS SQUIBB CO1 citations49

ZTE CORP

8 patents

FOXCONN KUNSHAN COMPUTER CONNECTOR CO LTD

3 patents

STATS CHIPPAC LTD

2 patents

MENG WEI

2 patents

RYONO DENIS E

2 patents

LIN YAOJIAN

1 patent

UNIV GUANGDONG TECHNOLOGY

1 patent

CHINESE RES ACAD ENV SCIENCES

1 patent

UNITED MICROELECTRONICS CORP

1 patent

LI GUOPING

1 patent

GUANGZHOU DONGSHENG BIOTECH CO LTD

1 patent

GLOBALFOUNDRIES SG PTE LTD

1 patent

KUNSHAN QTECH MICROELECTRONICS CO LTD

1 patent

ALIBABA GROUP HOLDING LTD

1 patent

Showing the top 50 of 64 patents by PatentIndex Score.